Establishment and Mechanistic Study of Venetoclax-Resistant Cell Lines in Acute Myeloid Leukemia.
10.19746/j.cnki.issn.1009-2137.2025.04.009
- Author:
Kai-Fan LIU
1
;
Ling-Ji ZENG
2
;
Su-Xia GENG
2
;
Xin HUANG
2
;
Min-Ming LI
2
;
Pei-Long LAI
2
;
Jian-Yu WENG
2
;
Xin DU
1
Author Information
1. School of Medicine, South China University of Technology, Guangzhou 510006, Guangdong Province, China.
2. Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510000, Guangdong Province, China.
- Publication Type:Journal Article
- Keywords:
acute myeloid leukemia;
venetoclax;
BCL-2 family;
resistance;
anti-apoptotic proteins
- MeSH:
Humans;
Sulfonamides/pharmacology*;
Drug Resistance, Neoplasm;
Bridged Bicyclo Compounds, Heterocyclic/pharmacology*;
Leukemia, Myeloid, Acute/pathology*;
Proto-Oncogene Proteins c-bcl-2/metabolism*;
Cell Line, Tumor;
Apoptosis;
Antineoplastic Agents/pharmacology*
- From:
Journal of Experimental Hematology
2025;33(4):986-997
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To establish venetoclax-resistant acute myeloid leukemia (AML) cell lines, assess the sensitivity of venetoclax-resistant cell lines to the BCL-2 protein family, and investigate their resistance mechanisms.
METHODS:CCK-8 method was used to screen AML cell lines (MV4-11, MOLM13, OCI-AML2) that were relatively sensitive to venetoclax. Low concentrations of venetoclax continuously induced drug-resistance development in the cell lines. Changes in cell viability and apoptosis rate before and after resistance development were measured using the CCK-8 method and flow cytometry. BH3 profiling assay was performed to anayze the transform of mitochondrion-dependent apoptosis pathway as well as the sensitivity of resistant cell lines to BCL-2 family proteins and small molecule inhibitors. Real-time fluorescence quantitative PCR (RT-qPCR) was utilized to examine changes in the expression levels of BCL-2 protein family members in both venetoclax-resistant cell lines and multidrug-resistant patients.
RESULTS:Venetoclax-resistant cell lines of MV4-11, MOLM13, and OCI-AML2 were successfully established, with IC50 values exceeding 10-fold. Under the same concentration of venetoclax, the apoptosis rate of resistant cells decreased significantly (P < 0.05). BH3 profiling assay revealed that the drug-resistant cell lines showed increased sensitivity to many pro-apoptotic proteins (such as BIM,BID and NOXA). RT-qPCR showed significantly upregulated MCL1 and downregulated NOXA1 were detected in drug-resistant cell lines. Expression changes in MCL1 and NOXA1 in venetoclax-resistant patients were consistent with our established drug-resistant cell line results.
CONCLUSION:The venetoclax-resistant AML cell lines were successfully established through continuous induction with low concentrations of venetoclax. The venetoclax resistance resulted in alterations in the mitochondrial apoptosis pathway of the cells and an increased sensitivity of cells to pro-apoptotic proteins BIM, BID, and NOXA, which may be associated with the upregulation of MCL1 expression and downregulation of NOXA1 expression in the drug-resistant cells.
